Adherium gets US sales approval

Australasian smart asthma inhaler device maker Adherium (ASX: ADR) has received US Food and Drug Administration clearance for over the counter sales of its Hailie sensors. The company, founded in New Zealand, listed in Australia and headquartered in the United States, manufactures connected respiratory devices. Its’ Hailie sensor attaches to a patient’s asthma inhaler, monitoring…

Lithium Australia closer to value-adding metals

Lithium Australia (ASX: LIT) has announced progress on a number of fronts in its strategy of developing value-adding businesses in the fast-growing lithium metal space. The company detailed significant progress in its technologies to produce lithium chemicals, produce lithium cathode powder, make lithium-ion batteries and in battery recycling. The company is also evaluating several potential…